State Street’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-149,762
| Closed | -$1.37M | – | 4739 |
|
|
2021
Q2 | $1.37M | Sell |
149,762
-517,084
| -78% | -$3.01M | ﹤0.01% | 3613 |
|
|
2021
Q1 | $3.31M | Sell |
666,846
-47,965
| -7% | -$232K | ﹤0.01% | 3224 |
|
|
2020
Q4 | $3.08M | Buy |
714,811
+15,119
| +2% | +$61.5K | ﹤0.01% | 3181 |
|
|
2020
Q3 | $3M | Buy |
699,692
+2,444
| +0.4% | +$10.2K | ﹤0.01% | 3036 |
|
|
2020
Q2 | $3.13M | Buy |
697,248
+4,670
| +0.7% | +$20.9K | ﹤0.01% | 2995 |
|
|
2020
Q1 | $2.77M | Sell |
692,578
-7,124
| -1% | -$60.5K | ﹤0.01% | 2914 |
|
|
2019
Q4 | $5.93M | Buy |
699,702
+55,013
| +9% | +$429K | ﹤0.01% | 2776 |
|
|
2019
Q3 | $4.42M | Buy |
644,689
+20,202
| +3% | +$148K | ﹤0.01% | 2850 |
|
|
2019
Q2 | $5.2M | Buy |
624,487
+90,614
| +17% | +$782K | ﹤0.01% | 2799 |
|
|
2019
Q1 | $4.9M | Buy |
533,873
+79,345
| +17% | +$806K | ﹤0.01% | 2756 |
|
|
2018
Q4 | $4.98M | Buy |
454,528
+52,194
| +13% | +$658K | ﹤0.01% | 2713 |
|
|
2018
Q3 | $5.61M | Buy |
402,334
+23,921
| +6% | +$324K | ﹤0.01% | 2811 |
|
|
2018
Q2 | $4.03M | Buy |
378,413
+25,770
| +7% | +$251K | ﹤0.01% | 2971 |
|
|
2018
Q1 | $3.05M | Buy |
352,643
+8,624
| +3% | +$75.7K | ﹤0.01% | 3001 |
|
|
2017
Q4 | $3.25M | Buy |
344,019
+54,709
| +19% | +$427K | ﹤0.01% | 2986 |
|
|
2017
Q3 | $2.27M | Buy |
289,310
+32,215
| +13% | +$242K | ﹤0.01% | 3149 |
|
|
2017
Q2 | $2.21M | Buy |
+257,095
| New | +$1.84M | ﹤0.01% | 3092 |
|
|
2015
Q2 | – | Sell |
-139,427
| Closed | -$996K | – | 3780 |
|
|
2015
Q1 | $996K | Buy |
139,427
+328
| +0.2% | +$2.26K | ﹤0.01% | 3228 |
|
|
2014
Q4 | $1.03M | Buy |
139,099
+406
| +0.3% | +$3.44K | ﹤0.01% | 3254 |
|
|
2014
Q3 | $1.29M | Buy |
138,693
+1,623
| +1% | +$21.9K | ﹤0.01% | 3181 |
|
|
2014
Q2 | $2.56M | Buy |
137,070
+62,439
| +84% | +$1.06M | ﹤0.01% | 2949 |
|
|
2014
Q1 | $1.38M | Buy |
+74,631
| New | +$1.42M | ﹤0.01% | 3184 |
|
Other funds holding KIN
State Street's KIN Position: Q3 2021 in Review
State Street sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 149,762 shares — an estimated $1.37M sold.
State Street first reported a position in KIN in Q1 2014 and held it in 22 quarters. The position peaked at $5.93M in Q4 2019. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.
- State Street reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
- State Street sold 149,762 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $1.37M.
- State Street first reported a position in Kindred Biosciences, Inc. in Q1 2014 and held it in 22 quarters.
- State Street's Kindred Biosciences, Inc. position peaked at $5.93M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.
Based on State Street's 13F filing for Q3 2021, filed 15 Nov 2021.